How do you assess whether an early-stage Hodgkin's patient is unfavorable?   

The unfavorable risk factors for stage I-II Classic Hodgkin's Lymphoma differ depending on the cooperative group (GHSG, EORTC, NCCN), which criteria do you use?  



Answer from: Radiation Oncologist at Academic Institution